Now Recruiting: Gynecologic Clinical Trials

As a National Cancer Institute-designated comprehensive cancer center, City of Hope is a nationally recognized leader in the research and treatment of gynecological cancers. City of Hope has been named a best hospital for cancer by U.S. News & World Report for two decades. This means patients at City of Hope have access to world-class care from a multidisciplinary team of experts who take an integrated, patient-centered approach to diagnose and treat ovarian, cervical, endometrial/uterine, vaginal, vulvar and fallopian tube cancers.
 
To refer a patient to one of our clinical trials, please call 626-218-1133 or visit CityofHope.org/Clinical-Trials.

Ovarian, Uterine, Appendiceal, Colorectal or Gastric Cancer

NCT04329494: Principal investigator Thanh H. Dellinger, M.D., is actively recruiting patients for a study on the benefits of pressurized intraperitoneal aerosol chemotherapy in treating patients with ovarian, uterine, appendiceal, stomach (gastric) or colorectal cancer that has spread to the lining of the abdominal cavity (peritoneal carcinomatosis).
 
Checklist icon
  • 18 years of age or older
  • Histologically confirmed ovarian, uterine, appendiceal, gastric or colorectal cancer with peritoneal metastases
  • Eastern Cooperative Oncology Group performance status ≤ 2